BHC · Bausch Health Companies Inc
United States · RS rating 73 · As of 2026-10-14
| Price | 5.89 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 73 / 87 / 91 / 39 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 22 / 30 / 17 |
| Industry group (rank) | Medical-Ethical Drugs (91) |
| EPS growth Q/Q | -162.5% |
| Sales growth Q/Q | +4.3% |
| Distance from 52-week high | +25.4% |
| Market cap (USD) | $2.1B |